Skip to content

To report a communicable disease, please call: 541-266-6700

Wastewater monitoring is conducted by the state for certain areas of Oregon. The data shows where the virus is detected in small- to medium-sized communities around the state.

Currently there are 29 communities participating on the project. A map shows if COVID-19 is “detected” or “not detected” in a community. It is important to note that if the virus was “not detected”, it does not mean that the community is free of COVID-19. Instead, it means that the virus may still be present in the area but below detection levels.

The monitoring serves as an “early warning” system to tell us if COVID-19 is spreading silently in communities. It is meant to help public officials try to prevent potential outbreaks or, if necessary, move resources to a community. OHA launched the project in the early fall with funding from the CDC.

https://public.tableau.com/app/profile/oregon.health.authority.covid.19/viz/OregonsSARS-CoV-2WastewaterMonitoring/WastewaterDashboard

COVID-19 Testing

COVID-19 Vaccine Information

You can check with your medical provider as many area providers, including pediatricians, do have vaccines available. Vaccine appointments can be made at the following locations:

  • Coquille Valley Hospital: 541-396-3101
  • Southern Coos Hospital: 541-347-2426
  • Bay Area Hospital: https://bayareahospital.org/covid-19/
  • Coos Health & Wellness: 541-266-6700
  • Broadway Pharmacy: 541-449-9190
  • North Bend Medical Center: 541-266-1788
  • Coast Community Health Center: 541-347-2529
  • Nova Health North Bend Clinic: https://www.novahealth.com OR 541-305-4224 option #2
No. North Dakota Public Health has put out a great one-pager https://files.constantcontact.com/d1037590101/06c2c73b-feb0-4eff-b70a-f45a417ae9b6.pdf that addresses this question in depth that has been reviewed by OHA and approved to send to all of you. We will have a Spanish version coming shortly.

You may be wondering what the difference is between an Emergency Use Authorization (EUA) and approval from the U.S. Food and Drug Administration (FDA). We’ll use this article to explore the topic in general, but we’ve posted a longer version on our blog with more details.

FDA Approval

In the case of an FDA approval, the FDA analyzes data on “the safety, efficacy, purity and potency” of every vaccine through a rigorous testing process, which usually begins with testing in animals.

If animals experience the intended effect of vaccination without concerning side effects, then the testing will continue in human trials, which are carried out in three phases.

If the clinical trials are considered a success, the FDA will also evaluate the vaccine manufacturing processes in place to ensure the vaccine can be made safely and consistently.

Following testing, FDA scientists and medical professionals carefully review all collected data and decide whether the vaccine is sufficiently safe and beneficial for use. If the vaccine meets these criteria, it is distributed for use in the United States and monitored closely thereafter. 

When a vaccine receives FDA approval, health care providers with prescribing rights may prescribe it to their patients as they see fit.

Emergency Use Authorization

The COVID-19 vaccines from Pfizer, Moderna and Johnson & Johnson have all received an Emergency Use Authorization (EUA) from the FDA. EUAs are granted only during a declared emergency like the COVID-19 pandemic.

Similar to the FDA approval process, vaccine studies for EUA are conducted across three phases. All three COVID-19 vaccines currently authorized for emergency use were studied in tens of thousands of volunteers from diverse backgrounds and regions, with data monitored by independent data safety monitoring boards.

If the trials indicate that the vaccine is safe and effective for use, the manufacturer may apply to FDA for EUA. Then, FDA scientists and physicians with expertise in vaccine research evaluate the data, alongside a group of public health experts who make up the Vaccines and Related Biological Products Advisory Committee (VRBPAC). That committee makes a recommendation to FDA.

Weighing all the evidence, along with the VRBPAC, the FDA decides whether the benefits of a vaccine are likely to outweigh its risks. If the vaccine meets these criteria, it is granted an EUA and distributed for use in the United States and monitored closely thereafter. The EUA specifies how the vaccine must be used and it is valid only for the duration of the declared emergency.

FDA approval and EUA are two different processes that the FDA can use to make a vaccine available. Both of them follow the rigorous safety standards set forth by the FDA.

Frequently Asked Questions

Flu vs. COVID-19

Symptoms:

Flu viruses can cause mild to severe illness, including common signs and COVID-19 symptoms.

COVID-19 seems to cause more serious illnesses, in some people. Other signs and symptoms of COVID-19, different from flu, may include change in or loss of taste or smell.

Spread:

Most people with the flu are contagious for about 1 day before they show symptoms. For those with COVID-19, it’s possible for people to spread the virus for about 2 days before experiencing signs or symptoms and remain contagious for at least 10 days after signs and symptoms first appeared.

Complications:

Both COVID-19 and flu can result in complications, including:

  • Pneumonia
  • Respiratory failure
  • Acute respiratory distress syndrome (i.e. fluid in lungs)
  • Sepsis
  • Cardiac injury (e.g. heart attacks and stroke)
  • Multiple-organ failure (respiratory failure, kidney failure, shock)
  • Worsening of chronic medical conditions (involving the lungs, heart, nervous system or diabetes)
  • Inflammation of the heart, brain or muscle tissues
  • Secondary bacterial infections (i.e. infections that occur in people who have already been infected with flu or COVID-19)

COVID-19 Additional Complications:

  • Blood clots in the veins and arteries of the lungs, heart, legs or brain
  • Multisystem Inflammatory Syndrome in Children (MIS-C)
New Virus Variation and What We Know

Contact Us

Please feel free to reach out to us should you have any questions:

Por favor, no dude en commincarse con nosotros si tiene alguna pregunta:

covid19.questions@chw.coos.or.us
541-266-6829

Treating Covid-19

Information and Resources for the Public

Current information is available on this site:

COVID-19 Funeral Assistance | FEMA.gov

Here are a few high level bullet points from the website:

  • In April, FEMA will begin accepting applications.
  • FEMA is working to set up a dedicated phone number that can be used to apply for funeral assistance.
  • The death must have occurred in the United States, including the U.S. territories, and the District of Columbia.
  • The death certificate must indicate the death was attributed directly or indirectly to COVID-19.
  • Additional guidance is being finalized and will be released to potential applicants and community partners as soon as possible. In the meantime, people who have COVID-19 funeral expenses are encouraged to keep and gather documentation.

Apply for food, cash and other assistance from home. All Oregonians can apply for food, cash and child care assistance provided through the Oregon Department of Human Services (ODHS) from home without having to visit an office in person. To apply from home, visit govstatus.egov.com/or-dhs-benefits for information on how to apply for assistance using an online application, email, mail, telephone or application drop off. Oregonians who need urgent and ongoing food assistance can visit needfood.oregon.gov. For more ways to connect with ODHS or to find other types of assistance, contact 211info:

Volunteer Opportunities

In coordination with the Emergency Operations Crew for Coos County, it is important to ensure that the most vulnerable people receive help and that all volunteers and recipients of support are safe. If you’re healthy and low risk and would like to help and volunteer, please email Angela Mayfield, Volunteer Coordinator, at: Angela.Mayfield@chw.coos.or.us or call 541-266-6703.

Emergency Fund For The Homeless

If you want to contribute to the work for the homeless task force for COVID-19 and ensure that people could self-isolate if they were positive with the virus, please go to: emergencyfundforthehomeless.com

Hand-sewn Face Masks

CDC Guidance: Use of Cloth Face Coverings to Help Slow the Spread of COVID-19

Oregon Guidance on Use of Homemade Masks or Face Coverings by the Public to Prevent Spread of COVID-19: April 4, 2020

Bay Area Hospital is accepting donations of sewn face masks (hospital-approved patterns can be found on their Facebook page) from the general community.

Donations can be delivered to the screening stations at either the main hospital entrance or at the Emergency Room entrance between the hours of 7:00 am and 5:00 pm.

Donations are also being collected at Coos Head Co-Op located at 353 S 2nd Street in Coos Bay. They are open Monday-Friday from 9:00 am to 7:00 pm, Saturdays from 9:00 am to 6:00 pm, and Sundays from 10:00 am to 6:00 pm.

Click HERE for hospital-approved face mask patterns from Bay Area Hospital Facebook page.

Informational Videos

Novel Coronavirus 2019 Public Service Announcements

14Oct 22

Jynneos Vaccine Eligibility Criteria 

The Jynneos vaccine, the vaccine currently used for Monkeypox, is becoming more available throughout the nation. Coos Health & Wellness has a limited supply of the vaccine and will be implementing a screening process for…

Read more
Back To Top